New Key Statistics Module, Z-Score and F-Score
OSTO:BIOVIC B Key Ratios
| Market Cap kr M | 201.73 |
| Enterprise Value kr M | 104.71 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.49 |
| Price/Sales | 18.04 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 6.00 |
| EPS (TTM) kr | -2.57 |
| Beneish M-Score | -1.93 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -26.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.86 |
| EV-to-EBITDA | -0.95 |
| PEG | -- |
| Shares Outstanding M | 84.06 |
| Net Margin (%) | -1,938.68 |
| Operating Margin % | -1,929.00 |
| Pre-tax Margin (%) | -1,899.51 |
| Quick Ratio | 7.10 |
| Current Ratio | 7.27 |
| ROA % (ttm) | -79.48 |
| ROE % (ttm) | -96.30 |
| ROIC % (ttm) | -195.74 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.54 |
OSTO:BIOVIC B Number of Guru Trades
OSTO:BIOVIC B Volume of Guru Trades
Gurus Latest Trades with OSTO:BIOVIC B
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OSTO:BIOVIC B is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers